
    
      This is a multi-center, randomized, double-blind, placebo-controlled study This study is
      planned to commence after obtaining Ethics Committee approval. participants will be
      randomised to a one-year course of alendronate sodium vitamin D3 tablets or placebo. 1:1
      double blinded randomisation will be undertaken. This study plans to enroll 60 participants
      and will be carried out in three domestic centers (Peking Union Medical College Hospital,
      Zhongshan Hospital and The Third Affiliated Hospital of Southern Medical University) with a
      follow-up period of 2 years.

      As the main goal of this exploratory study is to evaluate the effect of alendronate sodium
      vitamin D3 tablets compared with placebo on the improvement of joint structure and joint pain
      in participants with knee osteoarthritis. The primary outcome measure is WORMS score of knee
      joint MRI at 6 months and 12 months.
    
  